In the financial year 2008/09, Chr Hansen reached a revenue of €511m, which represents an increase of 7.2% compared to last year. While the exchange rates developed negatively, the company increased its sales in local currencies by 10% on the more than 140 markets where its bioscience products are sold.
“We’re extremely satisfied that during challenging times, we’re able to not only grow our revenue and gain market shares but also to increase our earnings – not least our ability to generate liquidity,” said Lars Frederiksen, CEO. “It’s especially satisfactory that our sales growth covers both products and markets. We have created a strong and growth-driven company based on a solid bioscience platform.”
Source: Chr Hansen
© FoodBev Media Ltd 2020
World Dairy Innovation Awards – OPEN FOR EARLY BIRD ENTRIES!
The awards celebrate excellence and innovation across the global dairy industry.
Don’t miss out on having your innovations recognised on a global scale.
Early bird deadline 19 March – enter now!